Congratulations to Samira Sakhia (BCom’90, DPA’94, MBA’01), who will take on a new challenge as President and Chief Executive Officer of Knight Therapeutics Inc., a Montreal-based company focused...
While leading a pharmaceutical company, Samira Sakhia (BCom’90, DPA’94, MBA’01) is also volunteering her expertise in the broader McGill community and supporting students in realizing their...
Samira Sakhia, BCom’90, DPA’94, MBA’01, entered the BCom program as a self-described “numbers person” and naturally gravitated towards earning a Chartered Professional Accountant (CPA) designation...
Knight Therapeutics has announced the resignation of its chief financial officer, as the company’s president and Desautels International Faculty Advisory Board member, Samira Sakhia (BCom’90, DPA...
At the Bloom Burton & Co Healthcare Investor Conference this May, Knight Therapeutics’ president, Samira Sakhia (BCom’90, DPA’94, MBA’01) will be giving the Montreal-based specialty...
In its 2016 financial results press release, Mississauga-based Profound Medical announced the appointment of Samira Sakhia (BCom’90, MBA’01) to its Board of Directors. Ms. Sakhia is also a member...
Knight Therapeutics Inc. (TSX: GUD) ("Knight"), a leading Canadian specialty pharmaceutical company, today announced that Samira Sakhia, former CFO of Paladin Labs Inc. ("Paladin"), will be joining...
Samira Sakhia, president of Knight Therapeutics, has joined Crescita Therapeutics Inc.’s board of directors. Prior to her current role, she was the chief financial officer of Paladin Labs. She...
Nuvo Research Inc. (TSX:NRI) (Nuvo or the Company), a specialty pharmaceutical company with growing revenues and a diverse portfolio of topical and immunology products, today announced the...
RSS